13.73
Schlusskurs vom Vortag:
$13.45
Offen:
$13.29
24-Stunden-Volumen:
800.53K
Relative Volume:
0.63
Marktkapitalisierung:
$1.19B
Einnahmen:
$4.15B
Nettoeinkommen (Verlust:
$-22.20M
KGV:
-196.14
EPS:
-0.07
Netto-Cashflow:
$-243.60M
1W Leistung:
+11.44%
1M Leistung:
+45.83%
6M Leistung:
-34.37%
1J Leistung:
-12.83%
Calumet Inc Stock (CLMT) Company Profile
Firmenname
Calumet Inc
Sektor
Branche
Telefon
(317) 328-5660
Adresse
1060 N CAPITOL AVE, INDIANAPOLIS
Vergleichen Sie CLMT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CLMT
Calumet Inc
|
13.73 | 1.07B | 4.15B | -22.20M | -243.60M | -0.07 |
![]()
LIN
Linde plc Ordinary Share
|
457.77 | 213.08B | 33.02B | 6.61B | 4.91B | 13.77 |
![]()
SHW
Sherwin Williams Co
|
363.51 | 88.18B | 23.04B | 2.68B | 2.18B | 10.58 |
![]()
ECL
Ecolab Inc
|
259.09 | 71.64B | 15.68B | 2.10B | 1.50B | 7.36 |
![]()
APD
Air Products Chemicals Inc
|
278.93 | 60.34B | 12.02B | 1.53B | -4.33B | 6.88 |
![]()
DD
Dupont De Nemours Inc
|
69.32 | 27.94B | 12.39B | 703.00M | 1.42B | 1.67 |
Calumet Inc Stock (CLMT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-13 | Eingeleitet | BofA Securities | Buy |
2025-03-17 | Hochstufung | UBS | Sell → Neutral |
2025-03-04 | Herabstufung | TD Cowen | Buy → Hold |
2025-02-04 | Herabstufung | UBS | Neutral → Sell |
2024-11-11 | Bestätigt | TD Cowen | Buy |
2024-10-17 | Bestätigt | TD Cowen | Buy |
2024-08-12 | Bestätigt | TD Cowen | Buy |
2022-08-18 | Hochstufung | Goldman | Neutral → Buy |
2022-02-28 | Bestätigt | Cowen | Outperform |
2022-01-06 | Eingeleitet | Credit Suisse | Neutral |
2021-11-23 | Hochstufung | Cowen | Market Perform → Outperform |
2021-11-23 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2021-10-04 | Eingeleitet | H.C. Wainwright | Buy |
2021-03-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2020-02-11 | Hochstufung | Raymond James | Underperform → Mkt Perform |
2017-09-05 | Herabstufung | Janney | Buy → Neutral |
2017-08-14 | Hochstufung | Janney | Neutral → Buy |
2017-05-10 | Hochstufung | Wells Fargo | Market Perform → Outperform |
2017-03-24 | Herabstufung | Credit Suisse | Neutral → Underperform |
2016-11-04 | Hochstufung | Credit Suisse | Underperform → Neutral |
2016-09-09 | Eingeleitet | FBR Capital | Mkt Perform |
2016-05-06 | Bestätigt | RBC Capital Mkts | Sector Perform |
2016-05-05 | Bestätigt | Cowen | Market Perform |
2016-05-05 | Hochstufung | DA Davidson | Underperform → Neutral |
2016-04-22 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
2016-04-19 | Herabstufung | DA Davidson | Buy → Underperform |
2016-04-18 | Bestätigt | Cowen | Market Perform |
2016-04-18 | Herabstufung | Raymond James | Mkt Perform → Underperform |
2016-04-18 | Bestätigt | Scotia Howard Weil | Sector Underperform |
2016-04-18 | Herabstufung | Wells Fargo | Outperform → Market Perform |
2016-04-11 | Herabstufung | Credit Suisse | Outperform → Underperform |
2016-02-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
2016-02-18 | Bestätigt | RBC Capital Mkts | Outperform |
Alle ansehen
Calumet Inc Aktie (CLMT) Neueste Nachrichten
Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
A ‘sustainable’ shift at the Great Falls refinery could come with costs to locals - Montana Free Press
Insider Sell Alert: Daniel Sheets Sells 40,000 Shares of Calumet Inc (CLMT) - GuruFocus
Bank of America Initiates Coverage on Calumet Specialty Products Partners (NASDAQ:CLMT) - MarketBeat
HC Wainwright Has Negative Forecast for CLMT FY2029 Earnings - MarketBeat
Calumet Specialty Products Partners (NASDAQ:CLMT) Posts Earnings Results, Misses Estimates By $0.62 EPS - MarketBeat
Calumet (CLMT) Price Target Reduced as Cost Efficiency Improves - GuruFocus
BofA sets Calumet stock to Buy, $15 target on biofuel prospects - Investing.com Nigeria
Montana Renewables to expedite first phase of MaxSAF initiative - Biomass Magazine
Calumet Renewables Expansion Is Unlocking Value: Analyst - AOL.com
Calumet (CLMT) Receives Buy Rating Due to Promising Biofuel Expa - GuruFocus
Calumet launched at Buy by BofA, as renewables growth seen driving deleveraging - Seeking Alpha
Calumet (CLMT) Receives 'Buy' Rating from B of A Securities | CL - GuruFocus
BofA Securities Initiates Calumet at Buy With $15 Price Target - marketscreener.com
Calumet, Inc. /DE SEC 10-Q Report - TradingView
Calumet, Inc. (NASDAQ:CLMT) Q1 2025 Earnings Call Transcript - Insider Monkey
Calumet Q1 2025 slides: MaxSAF acceleration and improved renewables performance - Investing.com
Calumet outlines $20M–$30M capital plan for MaxSAF 150 expansion with early 2026 target - MSN
Calumet Specialty Products Reports Q1 2025 Results - TipRanks
Calumet earnings missed by $1.49, revenue topped estimates - Investing.com Nigeria
Earnings call transcript: Calumet Inc. reports Q1 2025 earnings miss By Investing.com - Investing.com India
Calumet (CLMT) Reports Q1 EPS Loss, Revenue Dips Slightly - GuruFocus
Calumet (CLMT) Achieves Key Milestones Amid Deleveraging Efforts - GuruFocus
Earnings call transcript: Calumet Inc. reports Q1 2025 earnings miss - Investing.com
CLMT Reports Q1 Revenue Drop, Accelerates Growth Plans | CLMT St - GuruFocus
Earnings Flash (CLMT) Calumet Posts Q1 Sales $993.9M, vs. FactSet Est of $891.4M - marketscreener.com
CLMT Reports Q1 Revenue Drop, Accelerates Growth Plans | CLMT Stock News - GuruFocus
Calumet Reports First Quarter 2025 Results - Yahoo Finance
Calumet Inc (CLMT) Q1 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
Calumet Specialty Products Partners (CLMT) Expected to Announce Earnings on Friday - MarketBeat
Calumet Specialty Products Partners (NASDAQ:CLMT) Trading Up 4.6%Still a Buy? - MarketBeat
Calumet: Debt Relief Or Just Delaying The Inevitable? (NASDAQ:CLMT) - Seeking Alpha
Calumet Inc (CLMT) Stock Price Up 3.2% on Apr 28 - GuruFocus
Calumet Specialty Products Partners (NASDAQ:CLMT) Shares Down 2.8%Time to Sell? - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
Calumet, Inc. to Release First Quarter 2025 Earnings on May 9, 2 - GuruFocus
Calumet, Inc. to Release First Quarter 2025 Earnings on May 9, 2025 - Yahoo Finance
Polyol Ester Market Set to Witness Significant Growth by 2032 | - openPR.com
Brokerages Set Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) PT at $19.80 - MarketBeat
Calumet's Businesses Firing Like A Cannon, Well, Even Much Closer (Update) (NASDAQ:CLMT) - Seeking Alpha
Calumet Specialty Products Partners (NASDAQ:CLMT) Shares Up 5.2%Should You Buy? - MarketBeat
It's Down 29% But Calumet, Inc. (NASDAQ:CLMT) Could Be Riskier Than It Looks - simplywall.st
Calumet Specialty Products Partners (NASDAQ:CLMT) Stock Price Down 12.3% on Analyst Downgrade - MarketBeat
Calumet, Inc. (CLMT): A Bull Case Theory - Insider Monkey
Finanzdaten der Calumet Inc-Aktie (CLMT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Calumet Inc-Aktie (CLMT) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Sheets Daniel L | Director |
May 14 '25 |
Sale |
13.79 |
10,000 |
137,900 |
26,824 |
Mawer Stephen P | Director |
Apr 22 '25 |
Sale |
9.29 |
3,655 |
33,955 |
283,652 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):